BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30987832)

  • 1. Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.
    Sanguedolce F; Russo D; Calò B; Cindolo L; Carrieri G; Cormio L
    Pathol Res Pract; 2019 Jun; 215(6):152413. PubMed ID: 30987832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.
    Jung M; Kim B; Moon KC
    Histopathology; 2019 Feb; 74(3):483-493. PubMed ID: 30286252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
    Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
    McKenney JK; Desai S; Cohen C; Amin MB
    Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?
    Di Sciascio L; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Massari F; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
    Pathol Res Pract; 2022 Jun; 234():153937. PubMed ID: 35561522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic algorithm for papillary urothelial tumors in the urinary bladder.
    Shim JW; Cho KS; Choi YD; Park YW; Lee DW; Han WS; Shim SI; Kim HJ; Cho NH
    Virchows Arch; 2008 Apr; 452(4):353-62. PubMed ID: 18311491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations.
    Bang H; Park H; Park S; Choi E; Cho MS; Sung SH; Choi SY; Cho YM; Jeong SU; Ro JY
    Ann Diagn Pathol; 2020 Feb; 44():151433. PubMed ID: 31785538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Jones TD; Cheng L
    Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.
    Suryavanshi M; Sanz-Ortega J; Sirohi D; Divatia MK; Ohe C; Zampini C; Luthringer D; Smith SC; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):151-160. PubMed ID: 28398953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.
    Harnden P; Mahmood N; Southgate J
    Lancet; 1999 Mar; 353(9157):974-7. PubMed ID: 10459907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature.
    Jaworski D; Szylberg Ł; Gzil A; Stawinski P; Kasperska A; Marszałek A
    Ann Diagn Pathol; 2019 Jun; 40():182-188. PubMed ID: 29395466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
    Sikic D; Keck B; Wach S; Taubert H; Wullich B; Goebell PJ; Kahlmeyer A; Olbert P; Isfort P; Nimphius W; Hartmann A; Giedl J;
    PLoS One; 2017; 12(6):e0179602. PubMed ID: 28632777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A useful panel in proliferative urothelial lesions: an analysis of cytokeratin 20, p53, CD44 and Ki-67 antigens].
    Russo S; Botti G; Vinaccia P; Iaccarino C; Maioli S; Del Prete D; Maiello FM
    Pathologica; 2007 Apr; 99(2):46-9. PubMed ID: 17633807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
    Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
    Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu.
    Jung S; Wu C; Eslami Z; Tanguay S; Aprikian A; Kassouf W; Brimo F
    Ann Diagn Pathol; 2014 Feb; 18(1):27-32. PubMed ID: 24321464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.